Sublingual‐swallow immunotherapy (SLIT) in patients with asthma due to house‐dust mites: a double‐blind, placebo‐controlled study
- 1 March 1999
- Vol. 54 (3), 249-260
- https://doi.org/10.1034/j.1398-9995.1999.00916.x
Abstract
A double‐blind, placebo‐controlled study was carried out in 85 patients with a well‐documented history of perennial asthma caused by house‐dust mites. Patients received either placebo or sublingual i...Keywords
This publication has 20 references indexed in Scilit:
- Sublingual immunotherapyClinical and Experimental Allergy, 1996
- Improving the quality of reporting of randomized controlled trials. The CONSORT statementJAMA, 1996
- Bee venom immunotherapy induces a shift in cytokine responses from a TH‐2 to a TH‐1 dominant pattern: comparison of rush and conventional immunotherapyClinical and Experimental Allergy, 1995
- A double‐blind, placebo‐controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extractAllergy, 1994
- A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patientsClinical and Experimental Allergy, 1994
- A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extractJournal of Allergy and Clinical Immunology, 1993
- Prediction of mite allergen levels by guanine measurements in house‐dust samplesAllergy, 1993
- Immunotherapy with a standardized Dermatophagoides pteronyssinus extractJournal of Allergy and Clinical Immunology, 1989
- Efficacy of grass–maize pollen oral immunotherapy in patients with seasonal hay‐fever: a double‐blind studyClinical and Experimental Allergy, 1987
- Low dose sublingual therapy in patients with allergic rhinitis due to house dust miteClinical and Experimental Allergy, 1986